Clinical Trial

Dyslipidemia and Diabetic Retinopathy

Study Description

Dyslipidemia and Diabetic Retinopathy

The purpose of this study is to determine if the reparative cells of blood vessels called endothelial progenitor cells(EPC) are defective in people with diabetes.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy

Healthy Controls 15 age matched control subjects

Additional Information

Official Study Title

Dyslipidemia and Diabetic Retinopathy

Clinical Trial ID

NCT03403283

ParticipAid ID

YerABd